Organization | Alameda Health System

Alameda Health System Report issue

Academic/Hospital Phase 2 Phase 4

Founded: Oakland California United States (1992)

Organization Overview

First Clinical Trial

2016

NCT02912195

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Alameda Health System | Alameda Health System - Highland Hospital | Alameda Health System, Highland Hospital | Andrew A Herring

Active Ingredients

Drugs in Phase 4 Trials (11)

acetaminophen (tylenol) (1 trial)

bupivacaine (Exparel) (1 trial)

fentanyl (Innovar) (1 trial)

gabapentin (neurontin) (1 trial)

hydrocodone (hycodan) (1 trial)

hydromorphone (diladid) (1 trial)

ibuprofen (motrin) (1 trial)

ketamine (ketalar) (2 trials)

ketorolac (acuvail) (1 trial)

lidocaine (xylocaine) (1 trial)

morphine (3 trials)

Drugs in Phase 2 Trials (1)

buprenorphine (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Emergencies (Phase 4)

Fractures, Bone (Phase 4)

Fractures, Multiple (Phase 4)

Rib Fractures (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 5
# of Trial APIs: 12